Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Published:

A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments

Abstract

Thermostable enzymes combine catalytic specificity with the toughness required to withstand industrial reaction conditions1,2. Stabilized enzymes also provide robust starting points for evolutionary improvement of other protein properties3. We recently created a library4 of at least 2,300 new active chimeras of the biotechnologically important5,6,7,8,9 cytochrome P450 enzymes. Here we show that a chimera's thermostability can be predicted from the additive contributions of its sequence fragments. Based on these predictions, we constructed a family of 44 novel thermostable P450s with half-lives of inactivation at 57 °C up to 108 times that of the most stable parent. Although they differ by as many as 99 amino acids from any known P450, the stable sequences are catalytically active. Among the novel functions they exhibit is the ability to produce drug metabolites. This chimeric P450 family provides a unique ensemble for biotechnological applications and for studying sequence-stability-function relationships.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1: Thermostabilities of parental and chimeric cytochromes P450 vary widely and are well predicted by an additive model.
Figure 2: Relative chimera thermostabilities and folding status can be predicted from sequence element frequencies in a multiple sequence alignment of folded proteins.

Similar content being viewed by others

Change history

  • 12 December 2007

    In the print version of this article and the version initially published online, the sentence starting with “The most thermostable 450 P450 chimera” contains an extra “450”. The correct sentence should start as follows “The most thermostable P450 chimera”.

References

  1. Niehaus, F., Bertoldo, C., Kahler, M. & Antranikian, G. Extremophiles as a source of novel enzymes for industrial application. Appl. Microbiol. Biotechnol. 51, 711–729 (1999).

    Article  CAS  Google Scholar 

  2. Zeikus, J.G., Vieille, C. & Savchenko, A. Thermozymes: biotechnology and structure-function relationships. Extremophiles 2, 179–183 (1998).

    Article  CAS  Google Scholar 

  3. Bloom, J.D., Labthavikul, S.T., Otey, C.R. & Arnold, F.H. Protein stability promotes evolvability. Proc. Natl. Acad. Sci. USA 103, 5869–5874 (2006).

    Article  CAS  Google Scholar 

  4. Otey, C.R. et al. Structure-guided recombination creates an artificial family of cytochromes P450. PLoS Biol. 4, e112 (2006).

    Article  Google Scholar 

  5. Guengerich, F.P. Cytochrome P450 enzymes in the generation of commercial products. Nat. Rev. Drug Discov. 1, 359–366 (2002).

    Article  CAS  Google Scholar 

  6. Urlacher, V.B. & Eiben, S. Cytochrome P450 monooxygenases: perspectives for synthetic application. Trends Biotechnol. 24, 324–330 (2006).

    Article  CAS  Google Scholar 

  7. Landwehr, M. et al. Enantioselective alpha-hydroxylation of 2-arylacetic acid derivatives and buspirone catalyzed by engineered cytochrome P450BM-3. J. Am. Chem. Soc. 128, 6058–6059 (2006).

    Article  CAS  Google Scholar 

  8. Otey, C.R., Bandara, G., Lalonde, J., Takahashi, K. & Arnold, F.H. Preparation of human metabolites of propranolol using laboratory-evolved bacterial cytochromes P450. Biotechnol. Bioeng. 93, 494–499 (2006).

    Article  CAS  Google Scholar 

  9. van Vugt-Lussenburg, B.M., Damsten, M.C., Maasdijk, D.M., Vermeulen, N.P. & Commandeur, J.N. Heterotropic and homotropic cooperativity by a drug-metabolising mutant of cytochrome P450BM3. Biochem. Biophys. Res. Commun. 346, 810–818 (2006).

    Article  CAS  Google Scholar 

  10. Landwehr, M., Carbone, M., Otey, C.R., Li, Y. & Arnold, F.H. Diversification of catalytic function in a synthetic family of chimeric cytochrome P450s. Chem. Biol. 4, 269–278 (2007).

    Article  Google Scholar 

  11. Dietterich, T.G. Approximate statistical tests for comparing supervised classification learning algorithms. Neural Comput. 10, 1895–1923 (1998).

    Article  CAS  Google Scholar 

  12. Fox, R. et al. Optimizing the search algorithm for protein engineering by directed evolution. Protein Eng. 16, 589–597 (2003).

    Article  CAS  Google Scholar 

  13. Amin, N. et al. Construction of stabilized proteins by combinatorial consensus mutagenesis. Protein Eng. Des. Sel. 17, 787–793 (2004).

    Article  CAS  Google Scholar 

  14. Lehmann, M. et al. The consensus concept for thermostability engineering of proteins: further proof of concept. Protein Eng. 15, 403–411 (2002).

    Article  CAS  Google Scholar 

  15. Steipe, B., Schiller, B., Pluckthun, A. & Steinbacher, S. Sequence statistics reliably predict stabilizing mutations in a protein domain. J. Mol. Biol. 240, 188–192 (1994).

    Article  CAS  Google Scholar 

  16. Johannes, T.W., Woodyer, R.D. & Zhao, H.M. Directed evolution of a thermostable phosphite dehydrogenase for NAD(P)H regeneration. Appl. Environ. Microbiol. 71, 5728–5734 (2005).

    Article  CAS  Google Scholar 

  17. Abernethy, D.R., Wainer, I.W., Longstreth, J.A. & Andrawis, N.S. Stereoselective verapamil disposition and dynamics in aging during racemic verapamil administration. J. Pharmacol. Exp. Ther. 266, 904–911 (1993).

    CAS  PubMed  Google Scholar 

  18. Busse, D., Cosme, J., Beaune, P., Kroemer, H.K. & Eichelbaum, M. Cytochromes of the P450 2C subfamily are the major enzymes involved in the O-demethylation of verapamil in humans. Naunyn Schmiedebergs Arch. Pharmacol. 353, 116–121 (1995).

    Article  CAS  Google Scholar 

  19. Meuldermans, W., Hendrickx, J., Lauwers, W., Hurkmans, R., Swysen, E. & Heykants, J. Excretion and biotransformation of astemizole in rats, guinea-pigs, dogs, and man. Drug Dev. Res. 8, 37–51 (1986).

    Article  CAS  Google Scholar 

  20. Heykants, J., Peer, A.V., Woestenborghs, R., Jageneaur, A. & Bussche, G.V. Dose-proportionality, bioavailability, and steady-state kinetics of astemizole in man. Drug Dev. Res. 8, 71–78 (1986).

    Article  CAS  Google Scholar 

  21. Wells, J.A. Additivity of mutational effects in proteins. Biochemistry 29, 8509–8517 (1990).

    Article  CAS  Google Scholar 

  22. Meyer, M.M., Hochrein, L. & Arnold, F.H. Structure-guided SCHEMA recombination of distantly related beta-lactamases. Protein Eng. Des. Sel. 19, 563–570 (2006).

    Article  CAS  Google Scholar 

Download references

Acknowledgements

The authors thank Christopher R. Otey and Marco Landwehr for their assistance. This work was supported in part by National Institutes of Health Grant R01 GM068664-01, Army Research Office Contract DAAD19-03-0004, Eli Lilly & Co. and a Howard Hughes Medical Institute predoctoral fellowship (to J.D.B.).

Author information

Authors and Affiliations

Authors

Contributions

Y.L., A.M.S. and F.H.A. designed the research; Y.L. and A.M.S. performed the research; Y.L., D.A.D., A.M.S., C.D.S. and J.D.B. contributed to the analytical tools; Y.L., D.A.D., A.M.S., C.D.S., J.D.B. and F.H.A. analyzed data; Y.L., D.A.D., A.M.S., C.D.S. and F.H.A. wrote the paper.

Corresponding author

Correspondence to Frances H Arnold.

Ethics declarations

Competing interests

The thermostable P450s described have been licensed for commercialization. Remuneration is already fixed and will not be affected by this paper. F.S.A. is in talks to serve as consultant to licensor.

Supplementary information

Supplementary Text and Figures

Supplementary Figs. 1–6 and Supplementary Tables 1–7 (PDF 148 kb)

Rights and permissions

Reprints and permissions

About this article

Cite this article

Li, Y., Drummond, D., Sawayama, A. et al. A diverse family of thermostable cytochrome P450s created by recombination of stabilizing fragments. Nat Biotechnol 25, 1051–1056 (2007). https://doi.org/10.1038/nbt1333

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/nbt1333

This article is cited by

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing